LENSAR, Inc. (LNSR)
5.60
-0.29
(-4.92%)
USD |
NASDAQ |
Apr 07, 15:59
LENSAR Cash from Investing (Quarterly) : 4.245M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Standard BioTools, Inc. | -8.04M |
| Ludwig Enterprises, Inc. | -0.0004M |
| QHSLab, Inc. | 0.00 |
| Zomedica Corp. | 2.227M |
| Intelligent Bio Solutions, Inc. | -0.0285M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.618M |
| Cash from Financing (Quarterly) | 0.474M |
| Free Cash Flow | -14.91M |
| Free Cash Flow Per Share (Quarterly) | 0.0512 |
| Free Cash Flow to Equity (Quarterly) | 0.763M |
| Free Cash Flow to Firm (Quarterly) | 0.618M |
| Free Cash Flow Yield | -22.92% |